Chronic airways disease

Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study
Hiroaki Ogata, Yoichiro Hirakawa, Koichiro Matsumoto, Jun Hata, Daigo Yoshida, Satoru Fukuyama, Hiromasa Inoue, Takanari Kitazono, Toshiharu Ninomiya, Yoichi Nakanishi

BMJ Open Mar 2019, 9 (3) e023673; DOI: 10.1136/bmjopen-2018-023673
Patients and informal caregivers’ experiences of burden of treatment in lung cancer and chronic obstructive pulmonary disease (COPD): a systematic review and synthesis of qualitative research
Kate Alice Lippiett, Alison Richardson, Michelle Myall, Amanda Cummings, Carl R May

BMJ Open Feb 2019, 9 (2) e020515; DOI: 10.1136/bmjopen-2017-020515
Hypersegmented airway neutrophils and its association with reduced lung function in adults with obstructive airway disease: an exploratory study
Ravi Lokwani, Peter A B Wark, Katherine J Baines, Daniel Barker, Jodie L Simpson

BMJ Open Jan 2019, 9 (1) e024330; DOI: 10.1136/bmjopen-2018-024330
Developing an intervention to increase REferral and uptake TO pulmonary REhabilitation in primary care in patients with chronic obstructive pulmonary disease (the REsTORE study): mixed methods study protocol
Frances Early, Patricia Wilson, Christi Deaton, Ian Wellwood, Terry Dickerson, James Ward, Lianne Jongepier, Ruth Barlow, Sally J Singh, John Benson, James Brimicombe, Lois Kim, Hena Haque, Jonathan Fuld

BMJ Open Jan 2019, 9 (1) e024806; DOI: 10.1136/bmjopen-2018-024806
Defining the risk factors for acute, subacute and chronic cough: a cross-sectional study in a Finnish adult employee population
Anne M Lätti, Juha Pekkanen, Heikki O Koskela

BMJ Open Jul 2018, 8 (7) e022950; DOI: 10.1136/bmjopen-2018-022950
Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2)
Vijay Kunadian, Danny Chan, Hani Ali, Nina Wilkinson, Nicola Howe, Elaine McColl, Jared Thornton, Alexander von Wilamowitz-Moellendorff, Eva-Maria Holstein, Graham Burns, Andrew Fisher, Deborah Stocken, Anthony De Soyza

BMJ Open May 2018, 8 (5) e020713; DOI: 10.1136/bmjopen-2017-020713
Real-world effects of medications for chronic obstructive pulmonary disease: protocol for a UK population-based non-interventional cohort study with validation against randomised trial results
Kevin Wing, Elizabeth Williamson, James R Carpenter, Lesley Wise, Sebastian Schneeweiss, Liam Smeeth, Jennifer K Quint, Ian Douglas

BMJ Open Mar 2018, 8 (3) e019475; DOI: 10.1136/bmjopen-2017-019475
Physiological responses to arm versus leg activity in patients with chronic obstructive pulmonary disease: a systematic review protocol
Erik Frykholm, Vanessa Pereira Lima, Tania Janaudis-Ferreira, Andre Nyberg

BMJ Open Feb 2018, 8 (2) e019942; DOI: 10.1136/bmjopen-2017-019942
Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study
Peter Hanlon, Barbara I Nicholl, Bhautesh Dinesh Jani, Ross McQueenie, Duncan Lee, Katie I Gallacher, Frances S Mair

BMJ Open Jan 2018, 8 (1) e018404; DOI: 10.1136/bmjopen-2017-018404
ABC Index: quantifying experienced burden of COPD in a discrete choice experiment and predicting costs
Lucas MA Goossens, Maureen PMH Rutten-van Mölken, Melinde RS Boland, Bas Donkers, Marcel F Jonker, Annerika HM Slok, Philippe L Salomé, Onno CP van Schayck, Johannes CCM in ’t Veen, Elly A Stolk

BMJ Open Dec 2017, 7 (12) e017831; DOI: 10.1136/bmjopen-2017-017831

Main menu

Chronic airways disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Chronic airways disease

Pages